Who Supplies Famotidine to India from ITALY

To import finished pharmaceutical formulations containing Famotidine into India, the foreign manufacturer must obtain an Import Registration Certificate and an Import License from the Central Drugs Standard Control Organization (CDSCO). The application process involves submitting Form 40/41, along with required documents such as the Free Sale Certificate, Good Manufacturing Practice (GMP) certificate, and Certificate of Pharmaceutical Product (CoPP). The registration is valid for three years from the date of issue. The timeline for obtaining the import drug registration varies, but it typically takes several months to complete the necessary procedures. For formulations under HS Code 30049039, compliance with the Drugs and Cosmetics Act, 1940, and the associated rules is mandatory.

Imported Famotidine formulations must undergo quality testing at CDSCO-approved laboratories. Batch-wise testing is required, and a Certificate of Analysis (CoA) must accompany each shipment. Stability data demonstrating compliance with International Council for Harmonisation (ICH) Zone IV guidelines is necessary. The formulations must meet the standards set by the Indian Pharmacopoeia. Upon arrival, customs drug inspectors conduct port inspections to verify compliance with these requirements.

Between 2024 and 2026, the CDSCO introduced stricter regulations for imported medicines to prevent the sale of unapproved or illegal drugs in the Indian market. Import registration and licenses became mandatory for all pharmaceutical imports, including finished formulations. The introduction of the Production Linked Incentive (PLI) scheme has impacted the import of finished formulations, encouraging domestic manufacturing and reducing reliance on imports. Bilateral agreements between India and Italy have facilitated smoother trade relations, but no specific concessions have been made for Italian-origin products.

India imports finished Famotidine formulations primarily due to the demand for patented or branded products, specific dosage forms not available domestically, and the need for consistent quality. The domestic manufacturing capacity for Famotidine formulations is limited, leading to a dependency on imports to meet market needs. The market size for Famotidine formulations in India is substantial, with a total export market of $55.8 million across 152 exporters to 66 countries.

The Basic Customs Duty (BCD) for HS Code 30049039 is 10%. An additional Social Welfare Surcharge (SWS) of 10% is applied on the BCD, resulting in a total duty of 11%. Integrated Goods and Services Tax (IGST) is applicable, but the exact rate depends on the product classification and is subject to change. There are no exemptions or preferential duty rates for Italian-origin products under the Most Favored Nation (MFN) status.

India sources Famotidine formulations from Italy due to the country's competitive advantages, including patented formulations, specialized dosage forms, and high-quality manufacturing standards. Italian manufacturers are known for their adherence to Good Manufacturing Practices (GMP) and compliance with international quality standards. Other suppliers, such as China, Germany, and the United States, also export Famotidine formulations to India, but Italy's reputation for quality and innovation gives it a competitive edge. Italy's share in the Indian Famotidine import market is significant, reflecting its strong position among exporting countries.

India imports Famotidine formulations from Italy due to the availability of patented formulations, specialized dosage forms, and high-quality manufacturing standards. Italian manufacturers offer formulations that may not be available domestically, fulfilling specific market needs. The adherence to international quality standards and GMP compliance by Italian manufacturers ensures the safety and efficacy of the imported products.

When compared to other origins such as China, Germany, and the United States, Italy offers competitive advantages in terms of product quality, regulatory compliance, and reliability. Italian manufacturers are known for their innovation and adherence to international standards, which can be a deciding factor for Indian importers seeking high-quality Famotidine formulations.

Indian importers face several supply chain risks when sourcing Famotidine formulations from Italy, including single-source dependency, currency fluctuations, regulatory changes, quality incidents, and shipping disruptions. To mitigate these risks, importers should consider diversifying their supplier base, closely monitoring currency exchange rates, staying updated on regulatory changes, and establishing contingency plans for potential shipping disruptions.

1. 1Dual-Sourcing: Engage multiple suppliers to reduce dependency on a single source.
2. 2Inventory Planning: Maintain optimal inventory levels to buffer against supply chain disruptions.
3. 3Payment Terms: Negotiate favorable payment terms, such as Letters of Credit (LC), Documents Against Acceptance (DA), or Documents Against Payment (DP).
4. 4Minimum Order Quantities (MOQs): Clarify MOQs with suppliers to ensure flexibility in procurement.
5. 5Supplier Qualification: Conduct thorough due diligence on suppliers to ensure compliance with quality and regulatory standards.

1. 1DGFT Importer Exporter Code (IEC): Obtain an IEC from the Directorate General of Foreign Trade.
2. 2CDSCO Form 40/41: Submit the application for import registration.
3. 3Drug Import License: Obtain the necessary license for importing pharmaceutical products.
4. 4No Objection Certificate (NOC): If required, obtain an NOC from the relevant authorities.